Chinese plant extract market development trend
Chinese plant extract market development trend of China's 80% although the plant extracts are exported, but did not master the international discourse. Almost all brands of extracts have been occupied by Japan and the United States, and our raw materials and plant extracts are still in early form of export-oriented processing of products. In addition, to avoid bad money good money by the dilemma, and to adapt to international standards, national standards developed plant extract
Chinese plant extract market development trend
Although 80% of China's plant extracts are exported, but did not master the international discourse. Almost all brands of extracts have been occupied by Japan and the United States, and our raw materials and plant extracts are still in early form of export-oriented processing of products. In addition, to avoid "bad money by good 'dilemma, and to adapt to international standards, the development of plant extracts national standards is imperative.
The first half of this year, exports of plant extracts has reached $ 310 million, an increase of 17.5%, is only an increase of Chinese goods, its growth led to the rise in Chinese exports.
Exports in the first half of plant extracts has been ranked first in exports of Chinese goods, and gradually increase the proportion, Chinese goods exports accounted for 47.2% of total exports.
Luo Yang analysis, plant extracts are mainly exported large number of products as food additives. Especially food colorings, demand increased substantially during the first half of this year, led to the export of whole plant extracts. Such as Mexico and some other countries, traditional eating habits are more sensitive to food colors, and thus the demand for certain food colorings larger exports to Mexico during the first half of this year's chili pigments were recorded.
"All along, the plant extracts are more stable international demand, relatively strong growth is expected in the second half of the export of plant extracts will continue to be maintained steadily trend. And this year the export tax rebate adjustment in some plant extracts have been recovery from 13% to 15%, export increased confidence in the export of China's enterprises will play a larger role in promoting. "Luo Yang said.
According to Zhejiang Pharmaceutical Co., Ltd. Chief adviser CONBA wish Peter good analysis estimates that the export of plant extracts as a main staple varieties of Ginkgo biloba extract, the international market has been as high as 70 billion U.S. dollars, Canadian pharmacies and hospitals in the domestic market has far exceeded $ 3.0 billion plant extracts market has become a huge number of pharmaceutical companies competing for the cake.
Plant extracts export surge also touched a sensitive nerve in many enterprises. Shanghai Medicines and Health Products Import and Export Corporation, General Manager Jiang Zhenwei told reporters that the United States and Europe because of the increased demand for plant extracts, businesses will adjust the export structure, in the second half ready to increase the plant extract products export.
Although plant extracts in the financial crisis continues to show resilience under the influence of the trend, but its deep-seated problems within the industry has become a plant extract further into the international market shackles.
"At present our business enterprises plant extracts about 2000, but truly international competitiveness of enterprises is not much difference between the industry concentration, the international competitiveness of small, although the plant provides 80% of our products are for export, but did not master the international discourse. "Luo Yang said so.
From our current situation of plant extracts industry, currently extract a single product without their own brands and patents, the lack of key technologies and market advantages; species-rich plant resources are not rational and effective use and development. New product development ability, brand awareness weak become the implant industry to a common problem.
As a result, plant extract new product development and brand protection, much industry attention. According to reports, the Chinese Medicines and Health Products Import and Export Chamber of Commerce organized the "Chinese plant extracts to enhance the international competitiveness of the industry forum" will be held in September, will explore the international market supplement hot plant components and Chinese business innovation and brand protection issues.
To imitate the current enterprises to plant more, but very few really unique product, the product homogeneous competition. And lower barriers to entry of plant extracts, once certain types of commodities in the international best-selling, easy to follow the trend of corporate herd, low-cost low cut-throat competition seriously.
A general review of the international market, almost all brands of extracts have been occupied by Japan and the United States, and plant extracts in China continue to be the form of raw materials and primary processing products export-oriented.
Study the practical reasons, Luo Yang said, mainly plant extracts standards. Plant extracts on the relevant standards, is still an industry standard, the lack of national standards.
It is precisely because standards are not uniform plant extracts, is not perfect, the existing industry standard is only for a plant extract product, while the plant extracts contained in the composition of the finished product, but not required, resulting in some bad business loophole, Add inferior material breach.
With Ginkgo biloba extract, for example, according to Kuang Shan Zhu said, the current market price is high and low acid acid is much higher, and some businesses to benefit, in violation of rules add high acid extract, ginkgo extract makes the price several times, resulting in the quality to compete with low-grade Ginkgo biloba extract Ginkgo biloba extract product embarrassment.
Recently, the U.S. has also raised the export of plant extracts products, raw materials must be certified by the U.S. cGMP. I wish Peter good that the surface, which China's export of plant extracts negative, but in fact it is conducive to China to implant industry norms.
In Guangdong, the introduction of differential pricing of drugs, allowing the implementation of differential pricing of some foreign products. I wish Peter good that this is the raw material of different drugs have a great relationship.
In order to meet international standards, has been the first to take the initiative CONBA Ginkgo biloba extract improves the standard. The revised draft of the 2010 edition of Pharmacopoeia, also adopted CONBA provide the advice of the Ginkgo biloba extract in the ginkgolide content from 15% to 12% in science and adjust.